Announcement on Subsidiary Obtaining Drug Supplementary Application Approval
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Subsidiary Obtaining Drug Supplementary Application Approval
Filed with SSE ·
6ix hasn’t read this filing yet.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited on 6ix
Earlier from Guangzhou Baiyunshan Pharmaceutical
- Announcement on Resolution of the 26th Meeting of the 9th Board of Directors
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Resolutions of 2024 Annual General Meeting
- Announcement on Obtaining Approval for Marketing of Chemical APIs by Branch
- "Corporate Value and Return Enhancement" Action Plan 2025
Later from Guangzhou Baiyunshan Pharmaceutical
- Announcement on Participation in the Investment and Establishment of Equity Investment Fund and Related Party Transactions
- Full Text of 2025 Semi-annual Report
- Announcement on the Completion of Private Fund Filing and Progress of Related Party Transactions
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Announcement on Subsidiary Obtaining Approval for Marketing of Chemical APIs
Follow Guangzhou Baiyunshan Pharmaceutical into a list and get an email when it puts out news.
Follow Guangzhou Baiyunshan Pharmaceutical